SWP
ANIX icon

Stratos Wealth Partners’s Anixa Biosciences ANIX Stock Holding History

Stratos Wealth Partners’s Portfolio ANIX Stock Details ANIX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q4 		– Sell
-15,000
Closed -$47.3K – 1457
2024
Q3 		$47.3K Buy
+15,000
New +$46.1K ﹤0.01% 1416

Other funds holding ANIX

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
DADC
D.A. Davidson & Co Great Falls, Montana $16.5B AUM 19.94% 1-Year Est. Return
LNWTC
Laird Norton Wetherby Trust Company Seattle, Washington $4.58B AUM 30.77% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
MWM
Mission Wealth Management Santa Barbara, California $4.86B AUM 22.78% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
LFCM
Long Focus Capital Management San Juan, Puerto Rico $3.8B AUM 7.31% 1-Year Est. Return

Stratos Wealth Partners's ANIX Position: Q4 2024 in Review

Stratos Wealth Partners sold out of Anixa Biosciences (ANIX) in Q4 2024, closing a stake of 15,000 shares — an estimated $47.3K sold.

Stratos Wealth Partners first reported a position in ANIX in Q3 2024 and held it in 1 quarter. The position peaked at $47.3K in Q3 2024. 57 funds tracked by Wall St. Rank hold ANIX as of Q4 2024.

  • Stratos Wealth Partners reported no remaining Anixa Biosciences position as of Q4 2024 after selling out during the quarter.
  • Stratos Wealth Partners sold 15,000 Anixa Biosciences shares in Q4 2024, an estimated $47.3K.
  • Stratos Wealth Partners first reported a position in Anixa Biosciences in Q3 2024 and held it in 1 quarter.
  • Stratos Wealth Partners's Anixa Biosciences position peaked at $47.3K in Q3 2024.
  • 57 funds tracked by Wall St. Rank held Anixa Biosciences as of Q4 2024.

Based on Stratos Wealth Partners's 13F filing for Q4 2024, filed 27 Jan 2025.